Table 2.

Fold changes in the expression levels of microRNAs after recovery period

	Cisplatin		Paclitaxel
	Fold change* (p‐value+)		Fold change* (p‐value+)
	Treated cells‡	Untreated cells§	Treated cells‡	Untreated cells§
miR‐143	2.4 (0.031)	1.4 (n.s.)	−1.4 (n.s.)	−2.2 (0.019)
miR‐145	3.5(0.028)	7.6 (0.009)	1.0 (n.s.)	2.0 (0.044)
miR‐183	3.5 (0.013)	10.5 (0.001)	−3.5 (0.013)	1.4 (n.s.)
miR‐96	−1.5 (n.s.)	2.5 (0.021)	−1.9 (0.048)	1.3 (n.s.)
miR‐182	−1.9(0.039)	2.6 (0.008)	−2.0 (0.034)	1.0 (n.s.)

^*Positive and negative values reflect increase and decrease in miRNA expression, respectively.

⁺n.s. stands for not significant variations (p‐value > 0.05).

^‡Fold changes in comparison with the relative levels of miRNAs detected in the 48‐hour treated cells.

^§Compared with the average of the relative miRNA levels measured in untreated (control) cells.